Barrington Research analyst Michael Petusky upgrades ModivCare (NASDAQ:MODV) from Market Perform to Outperform and announces $35 price target.
Barrington Research Upgrades ModivCare to Outperform, Announces $35 Price Target
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.